-
Creative Diagnostics Launches Humanized Monoclonal Antibodies for Assay Development
Aug 16, 2018, 03:07 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Aug 16, 2018 - As a global leader in the manufacture of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics announced today that it has launched a newly developed set of humanized monoclonal antibodies (IgM, IgG or IgA) that can be used as calibrators, positive, negative or quality controls in assay development and manufacturing of diagnostic kits for global life science researchersFull story -
CIO Perspective: Creating Community On Campus At St. Jude
Aug 15, 2018, 11:45 AM by Michael CroftFull storyBio-IT World | The process of creating the St. Jude Cloud was a difficult one for St. Jude Children’s Research Hospital. But St. Jude’s CIO and chair of Computational Biology believe the relationships cultivated during the process will create a user community as much within St. Jude as without.
-
Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities
Aug 15, 2018, 09:33 AM by Michael CroftPRINCETON, NJ - Aug 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10Full story -
Clues To Your Health Are Hidden At 6.6 Million Spots In Your DNA
Aug 14, 2018, 13:16 PM by Michael CroftThe New York Times | With a sophisticated new algorithm, scientists have found a way to forecast an individual's risks for five deadly diseases.Full story -
ActiveRADAR Expands Leadership Team to Support Industry Demand, Company Momentum
Aug 14, 2018, 11:00 AM by Michael CroftSACRAMENTO, CA, UNITED STATES - Aug 14, 2018 - ActiveRADAR (formerly known as RxTE Health), a company specializing in pharmacy cost reduction programs for employers, today announced the addition of three healthcare executives to its leadership teamFull story -
OmniTier’s CompStor Brings De Novo Analytics To Genomics
Aug 14, 2018, 08:05 AM by Michael CroftFull storyBio-IT World News Brief | OmniTier announced that in a joint study with researchers at the Mayo Clinic’s Center for Individualized Medicine, the company successfully demonstrated human DNA variant calling using de novo global assembly techniques with breakthrough performance and cost.
-
MDI Biological Laboratory Announces Morris Scientific Discovery Fund
Aug 13, 2018, 13:24 PM by Michael CroftBAR HARBOR, ME, UNITED STATES - Aug 13, 2018 - The MDI Biological Laboratory has announced the formation of the Morris Scientific Discovery Fund, which will provide a total of up to $250,000 per year for eligible research programsFull story -
Tjoapack launches postponement packaging service
Aug 13, 2018, 11:55 AM by Michael CroftETTEN-LEUR, NETHERLANDS - Aug 13, 2018 - Global contract packaging organisation (CPO), Tjoapack has launched a new postponement packaging service to help customers address supply chain challenges including variable demand and repackaging workFull story -
The Future Of Humans As Model Organisms
Aug 13, 2018, 10:14 AM by Michael CroftScience | A better grasp of the dynamic relationship between genes and the environment may truly sharpen our ability to determine disease risk and response to therapy, argues a recent perspective essay in Science.Full story -
BC Platforms and Negen Announce Partnership for Early Risk Assessment of Common Diseases
Aug 9, 2018, 16:07 PM by Michael CroftBASEL, SWITZERLAND - Aug 8, 2018 - BC Platforms, a world leader in genomic data management and analytics, today announces that it has signed a co-operation agreement with Negen to use its platform to provide detailed insights into raw genomic data for clinical reporting capabilitiesFull story -
KEY BIOLOGICS AND ASTARTE BIOLOGICS MERGE
Aug 9, 2018, 08:47 AM by Michael CroftMEMPHIS, TN, UNITED STATES - Aug 9, 2018 - KEY BIOLOGICS AND ASTARTE BIOLOGICS MERGEIncludes growth equity investment from Ampersand Capital PartnersKey Biologics, has completed its merger withAstarte Biologics to create the leading provider of research- and clinical-grade human immune cells, blood products, and related services to the biopharmaceutical industryFull story -
US Scientist Who Edited Human Embryos With CRISPR Responds To Critics
Aug 8, 2018, 13:49 PM by Michael CroftMIT Technology Review | Facing criticism from fellow scientists, the researcher behind the world's largest effort to edit human embryos with CRISPR is vowing to continue his effort to develop what he calls "IVF gene therapy."Full story -
A New Machine Learning Approach To Document Classification – A Pfizer/SciBite Collaboration
Aug 8, 2018, 12:10 PM by Michael CroftFull storyBio-IT World | To address the issues surrounding knowledge transfer, Pfizer and SciBite collaborated on the development of ClassifR, a web-based tool that combines SciBite’s NER platform with novel machine learning (ML) approaches to automate the process of metadata extraction and alignment of incoming documents against a user-defined hierarchy.
-
iGlucose® Joins the Validic Connected Health Ecosystem
Aug 7, 2018, 13:11 PM by Michael CroftTAMPA, FL - Aug 6, 2018 - Today, Smart Meter, LLC, makers of the iGlucose® Cellular Diabetes Care Solution, announced its integration with Validic, the healthcare industry's leading data connectivity platformFull story -
Quartzy Teams Up with BioBlaze to Democratize Science Across Chicago’s Biotech Community
Aug 7, 2018, 13:05 PM by Michael CroftPALO ALTO, CA, US - Aug 7, 2018 - Quartzy, the only free online laboratory supply management and ordering platform, announced today its partnership with South Elgin-based BioBlaze Community Bio Lab to provide the non-profits scientists with access to competitive terms on laboratory supplies and enhanced support tailored to their emergent scientific endeavorsFull story -
Oxford Genetics signs major supply and licensing agreement for CRISPR engineered mammalian cell lines
Aug 7, 2018, 09:35 AM by Michael CroftOXFORD, UK - Aug 7, 2018 - Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has secured a multi-million pound contract with a leading multi-billion dollar global ecommerce provider of reagents and tools to the research and clinical communityFull story -
Prototypes Of China’s Exascale Supercomputers Point To Some New Realities
Aug 6, 2018, 12:18 PM by Michael CroftTOP500 | Two prototypes of China's initial batch of exascale supercomputers are now up and running according to local news reports. And neither of them appears to be based on x86 technology.Full story -
Bluebird, Regeneron Team Up To Make Cell Therapies For Cancer
Aug 6, 2018, 08:13 AM by Michael CroftXconomy | Regeneron and Bluebird have struck a wide-ranging deal to broaden the reach of their respective cancer immunotherapy work, inking a deal to develop multiple cell therapies together.Full story -
Denial And Data Science: How You Must Change Your Thinking To Work In A Data Driven Environment
Aug 3, 2018, 08:25 AM by Michael CroftFull storyBio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Samantha G. Zeitlin about the optimal environment to grow data science, the skillsets necessary in the data science industry, and more.
-
World’s first hand-held infrared devices for COPD and other conditions to be produced following Glyconics agreement with Spectrolytic
Aug 3, 2018, 05:00 AM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Aug 3, 2018 - A hand-held device that would give early warning of acute events, and so avoid the hospitalisation of thousands of patients with chronic obstructive pulmonary disease (COPD), is to go into production ahead of clinical trialsFull story